Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.
OBJECTIVE
The aim of this research was to determine correlates of prevalent cervicovaginal human papillomavirus (HPV) infection in perimenopausal women.


METHODS
A total of 178 women, ages 40-60, were recruited from four clinics in the metropolitan area of Baltimore, Maryland. A self-collected cervicovaginal specimen and questionnaire were completed following enrollment and consent. HPV was detected by L1 consensus polymerase chain reaction (PCR) and genotyped using a prototype line blot assay. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) from Poisson regression models with robust variance identified correlates of prevalent HPV infection.


RESULTS
Prevalence of any HPV genotype at baseline among 172 women with complete data was 20% (6% for high-risk HPV). HPV prevalence was higher among single compared to married women (aPR = 4.3 [95% CI: 2.0, 9.5]), and among women with >or=2 sex partners in the last six months compared to women who reported none (aPR = 4.9 [1.7, 13.9]) after adjustment for confounders. Menopausal stage was also associated with HPV detection, with increased prevalence among perimenopausal compared to premenopausal women (aPR 2.3 [1.1, 5.1]), after adjustment for confounders. Age was moderately correlated with menopausal staging (r = 0.57).


CONCLUSIONS
Our observations suggest the independent associations of sexual behavior and hormones on prevalent HPV in perimenopausal women. Age was not a good surrogate for menopausal stage, as it was only moderately correlated with menopausal stage.
Althoff
Keri N
KN
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Paul
Proma
P
Burke
Anne E
AE
Viscidi
Raphael
R
Sangaramoorthy
Meera
M
Gravitt
Patti E
PE
D000328:Adult; D017677:Age Distribution; D003430:Cross-Sectional Studies; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D008396:Maryland / Q000453:epidemiology; D008875:Middle Aged; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000453:epidemiology*; D047648:Perimenopause; D016133:Polymerase Chain Reaction / Q000379:methods; D015995:Prevalence; D012307:Risk Factors; D012725:Sexual Behavior / Q000706:statistics & numerical data; D014626:Vaginal Smears / Q000706:statistics & numerical data*; D016387:Women's Health
D004279:DNA, Viral
Sex Transm Dis. 2007 Nov;34(11):849-55
17621246
Gynecol Oncol. 2007 May;105(2):530-5
17335880
J Clin Endocrinol Metab. 2004 Jun;89(6):2622-31
15181033
Lancet Infect Dis. 2007 Jul;7(7):453-9
17597569
J Natl Cancer Inst Monogr. 2003;(31):14-9
12807940
J Womens Health Gend Based Med. 2001 Nov;10(9):843-8
11747678
Gynecol Oncol. 1997 Jun;65(3):441-6
9190973
Sex Transm Dis. 2007 Jul;34(7):429-36
17075437
Endocr Rev. 2007 Aug;28(5):521-74
17640948
Lancet. 2005 Sep 17-23;366(9490):991-8
16168781
Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):95-100
11219778
J Clin Microbiol. 1998 Oct;36(10):3020-7
9738060
Nat Rev Cancer. 2002 May;2(5):342-50
12044010
Vaccine. 2008 Sep 2;26(37):4795-808
18640170
J Pathol. 1999 Sep;189(1):12-9
10451482
Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):7-23
19046657
Eur J Cancer Prev. 2002 Jun;11(3):295-305
12131663
Obstet Gynecol. 1997 Jul;90(1):7-11
9207803
Methods Inf Med. 2004;43(5):505-9
15702210
Cancer Detect Prev. 2003;27(6):472-80
14642556
J Clin Pathol. 2002 Apr;55(4):244-65
11919208
Sex Transm Infect. 2006 Aug;82(4):337-9
16877589
J Clin Microbiol. 2000 Jan;38(1):357-61
10618116